Selective recognition of bacterial phospholipids by antimicrobial peptides: Employing a host-guest-mediated competitive inhibition strategy
Source abstract
Abstract
The distinct phospholipid compositions of bacterial and mammalian cell membranes offer a promising target for the development of antimicrobial peptides (AMPs). However, distinguishing between the similarly charged anionic phospholipids-bacterial phosphatidylglycerol (PG) and mammalian phosphatidylserine (PS)-poses a significant challenge. Here we introduce a competitive inhibition strategy that leverages host-guest interactions to enable AMPs to selectively recognize PG without engaging with PS. After analyzing the binding interactions of various radially amphiphilic AMPs (RAPs), host molecules, and phospholipids, we discovered that a RAP, named C6HO, exhibited a higher affinity for cucurbit[7]uril (CB[7]) compared to PS, yet a lower affinity than for PG. Consequently, CB[7] functions as a competitive inhibitor: by forming a complex with C6HO upon simple mixing, it prevents C6HO from interacting with PS. Notably, PG can outcompete CB[7] for binding to C6HO within the complex, leading to the aggregation of PG molecules and the subsequent disruption of membranes rich in PG. Furthermore, the competitive inhibitor CB[7] effectively neutralizes C6HO's cytotoxic effects on mammalian cells while preserving the antimicrobial potency of C6HO. In vivo experiments in a subcutaneous infection model demonstrated that CB[7] reduced both systemic and local toxicity of C6HO without compromising its antimicrobial efficacy. Our study presents a strategy for the specific recognition of bacterial phospholipids and the design of highly selective AMPs.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Antimicrobial Peptides and Activities · RNA and protein synthesis mechanisms · Chemical Synthesis and Analysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (50)
Show source-provided references
1. Switching from membrane disrupting to membrane crossing, an effective strategy in designing antibacterial polypeptide10.1126/sciadv.abn0771 ↗
2. Bacterial defences: mechanisms, evolution and antimicrobial resistance10.1038/s41579-023-00877-3 ↗
3. Alternative therapeutic strategies to treat antibiotic-resistant pathogens10.1038/s41579-023-00993-0 ↗
4. Advances of antimicrobial peptide-based biomaterials for the treatment of bacterial infections10.1002/advs.202206602 ↗
5. Identification of potent antimicrobial peptides via a machine-learning pipeline that mines the entire space of peptide sequences10.1038/s41551-022-00991-2 ↗
6. The intricate link between membrane lipid structure and composition and membrane structural properties in bacterial membranes10.1039/D3SC04523D ↗
7. pH window for high selectivity of ionizable antimicrobial polymers toward bacteria10.1021/acsami.2c23240 ↗
8. Molecular mechanisms of antibiotic resistance revisited10.1038/s41579-022-00820-y ↗
9. Self-assembled cationic peptide nanoparticles as an efficient antimicrobial agent10.1038/nnano.2009.153 ↗
10. Antimicrobial peptide capsids of de novo design10.1038/s41467-017-02475-3 ↗
11. Pyrgos[n]cages: redefining antibacterial strategy against drug resistance
12. Antimicrobial peptides-mechanisms of action, antimicrobial effects and clinical applications10.3390/antibiotics11101417 ↗
13. Structural element of vitamin U-Mimicking antibacterial polypeptide with ultrahigh selectivity for effectively treating MRSA infections
14. Helicity- directed recognition of bacterial phospholipid via radially amphiphilic antimicrobial peptides10.1126/sciadv.adn9435 ↗
15. Antibiotics and hexagonal order in the bacterial outer membrane10.1038/s41467-023-40275-0 ↗
16. Biomaterial-based antimicrobial therapies for the treatment of bacterial infections10.1038/s41578-021-00362-4 ↗
17. Distribution, dynamics and functional roles of phosphatidylserine within the cell10.1186/s12964-019-0438-z ↗
18. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells, blood
19. Getting to the outer leaflet: physiology of phosphatidylserine exposure at the plasma membrane10.1152/physrev.00020.2015 ↗
20. Defensins: defenders of human reproductive health10.1093/humupd/dmac032 ↗
21. Defensins: the natural peptide antibiotic10.1016/j.addr.2021.114008 ↗
22. Recent advances in design of antimicrobial peptides and polypeptides toward clinical translation10.1016/j.addr.2020.12.016 ↗
23. Risk factors for polymyxin B-associated acute kidney injury10.1016/j.ijid.2022.01.055 ↗
24. Review: lessons learned from clinical trials using antimicrobial peptides (AMPs)10.3389/fmicb.2021.616979 ↗
25. Structural and functional insights into hemoglobinopathies: genetic mutations, diagnostic approaches and therapeutic strategies
26. The cellular thermal shift assay for evaluating drug target interactions in cells10.1038/nprot.2014.138 ↗
27. Mechanisms of backtrack recovery by RNA polymerases I and II10.1073/pnas.1517011113 ↗
28. Metabolic regulation: sensing ATP levels
29. Tamoxifen: a Most unlikely pioneering medicine10.1038/nrd1031 ↗
30. Mechanistic insights into the role of molecular chaperones in protein misfolding diseases: from molecular recognition to amyloid disassembly10.3390/ijms21239186 ↗
31. Real-time single-molecule observation of chaperone-assisted protein folding10.1126/sciadv.add0922 ↗
32. Structural mechanism of tapasin-mediated MHC-I peptide loading in antigen presentation10.1038/s41467-022-33153-8 ↗
33. A guide to antigen processing and presentation10.1038/s41577-022-00707-2 ↗
34. Structural insights into human MHC-II association with invariant chain10.1073/pnas.2403031121 ↗
35. MHC class II complexes sample intermediate states along the peptide exchange pathway10.1038/ncomms13224 ↗
36. An invariant road to cross-presentation10.1038/ni.2235 ↗
37. Recent advances in the synthesis and applications of macrocyclic arenes10.1039/D3CS00002H ↗
38. Cucurbituril‐based supramolecular polymers for biomedical applications10.1002/anie.202206763 ↗
39. Supramolecular prodrugs based on host-guest interactions10.1039/C9CS00622B ↗
40. Design of calixarene‐based ICD inducer for efficient cancer immunotherapy10.1002/adfm.202213967 ↗
41. Helical antimicrobial polypeptides with radial amphiphilicity10.1073/pnas.1507893112 ↗
42. One-pot synthesis of brush-like polymers via integrated ring-opening metathesis polymerization and polymerization of amino acid N-Carboxyanhydrides10.1021/ja903425x ↗
43. Modulation of conformational transition of polypeptides under slightly acidic environment10.1002/cjoc.202200483 ↗
44. Molecular details on the intermediate states of melittin action on a cell membrane10.1016/j.bbamem.2018.09.007 ↗
45. Structure-based derivation and intramolecular cyclization of peptide inhibitors from PD-1/PD-L1 complex interface as immune checkpoint blockade for breast cancer immunotherapy10.1016/j.bpc.2019.106213 ↗
46. Selective killing of Helicobacter pylori with pH-responsive helix-coil conformation transitionable antimicrobial polypeptides10.1073/pnas.1710408114 ↗
47. Drug delivery by supramolecular design10.1039/C7CS00391A ↗
48. Host-guest chemistry in supramolecular theranostics10.7150/thno.31653 ↗
49. Multicharged cyclodextrin supramolecular assemblies10.1039/D1CS00821H ↗
50. A supramolecular antibiotic switch for antibacterial regulation10.1002/anie.201504566 ↗